What's breaking now, across thousands of outlets.
KUBRA acquisition doubled pro forma revenue; management targets deleveraging below 3.0x in 18 months.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Warrant gains drove profitability despite 70% revenue decline; Q4 breakeven targeted.
Revenue declined 5% as management shifted focus to high-value direct members over growth.
Flow cell sales surged 27% as OGM adoption accelerates globally.
Tokenized stock market share has grown to 15%, up 3x from the start of the year, with the total market cap around $2.8 billion.
TD Securities’ Alex Loo highlights that China’s July data showed weaker industrial production, modest retail sales and record-weak Fixed Assets Investment, reinforcing concerns about insufficient…
Global oil prices surged up to 3% on Tuesday, with Brent crude exceeding $91 a barrel for the first time since late July.
